Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance
Kristína Kováčiková, Martijn J. van Hemert
Abstract
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has spread to more than 60 countries worldwide. CHIKV infection leads to a febrile illness known as chikungunya fever (CHIKF), which is characterized by long-lasting and debilitating joint and muscle pain. CHIKV can cause large-scale epidemics with high attack rates, which substantiates the need for development of effective therapeutics suitable for outbreak containment. In this review, we highlight the different strategies used for developing CHIKV small-molecule inhibitors, ranging from high-throughput cell-based screening to in silico screens and enzymatic assays with purified viral proteins.
Topics & Concepts
ChikungunyaAlphavirusVirologyVirusOutbreakAlphavirus infectionBiologyDrug resistanceDrugMicrobiologyPharmacologyMosquito-borne diseases and controlViral Infections and VectorsMalaria Research and Control